Hualan Vaccine

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Hemay Pharmaceutical Nets Nearly CNY 300 Mn in Series D

The innovative drug company aims to provide more effective, affordable, safer medicine for patients

Dynamic Biosystems Snags Nearly CNY 100 Mn in Series A+

Dynamic Biosystems is a single cell and space multi-omics technology platform enterprise. The company focuses on exploring the huge potential in the fields of precision medicine of tumor, eugenics and fertility, and drug discovery, and is committed to promoting precision medicine to the era of single cell and space omics, helping life science and clinical medicine.

Real And Best Nets Over CNY 200 Mn in Series A+

Gene therapy company Real And Best accelerates to promote pipelines covering genetic disease, metabolism, and aging

Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis

‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’